Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound
Open Access
- 1 September 1995
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 270 (38), 22467-22472
- https://doi.org/10.1074/jbc.270.38.22467
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- AN EVALUATION OF LEFLUNOMIDE IN THE CANINE RENAL TRANSPLANTATION MODEL1Transplantation, 1994
- Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomideFEBS Letters, 1993
- Pharmacologic manipulation of graft versus host induced splenomegalyInflammation Research, 1992
- Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejectionInflammation Research, 1991
- Evidence for the Importance of a Carboxyl Group in the Binding of Ligands to the D2 Dopamine ReceptorJournal of Neurochemistry, 1990
- Disease modifying activity of HWA 486 on the development of SLE in MRL/1-miceInflammation Research, 1986
- Analysis of radioligand binding experimentsJournal of Pharmacological Methods, 1985
- Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity — I. Disease modifying action on adjuvant arthritis of the ratInternational Journal of Immunopharmacology, 1985
- Improved Synthesis ofn-octyl-β-D-Glucoside: A Nonionic Detergent of Considerable Potential in Membrane BiochemistryMembrane Biochemistry, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970